Brydon Review

Brydon Review
Name	Brydon Review
Caption	Independent review into NHS laboratory services
Date	2017–2019
Authors	Professor Brian J. Brydon
Jurisdiction	United Kingdom
Outcome	Report with recommendations on pathology services

Brydon Review The Brydon Review was an independent inquiry into pathology and laboratory medicine services in the United Kingdom commissioned amid concerns about service quality, workforce sustainability, and technological integration. Chaired by Professor Brian J. Brydon, the Review examined relationships among NHS providers, regulatory bodies, professional colleges, and private sector partners, producing a series of recommendations aimed at modernising pathology networks and safeguarding patient safety. It drew on evidence from national institutions, professional organisations, academic centres, and international models of diagnostic services.

Background and establishment

The Review was commissioned by senior officials within the Department of Health and Social Care, prompted by reviews from bodies such as the National Institute for Health and Care Excellence, the Care Quality Commission, and reports involving the Royal College of Pathologists and the College of American Pathologists on laboratory standards. High-profile clinical incidents involving diagnostic errors and reports from the Francis Inquiry, Berwick Review, and the Mid Staffordshire NHS Foundation Trust public inquiry influenced ministers and health leaders to seek an expert appraisal. Stakeholders included the NHS England, Public Health England, the General Medical Council, and regional pathology consortia with input from university departments at institutions like University College London and the University of Oxford.

Scope and remit

The Review's remit covered service configuration, quality assurance, workforce planning, education and training, laboratory accreditation, and the adoption of digital pathology and laboratory information systems. It evaluated laboratory integration models exemplified by regional networks in Scotland, consolidation initiatives in Wales, and outsourced arrangements seen in collaborations with companies such as Sonic Healthcare and Eurofins Scientific. The Review considered regulatory frameworks including standards from the Health and Safety Executive and international benchmarks such as those applied by the World Health Organization and Organisation for Economic Co-operation and Development.

Key findings and recommendations

Brydon identified fragmentation across pathology services, variable workforce capacity, and uneven adoption of automation and digital pathology platforms. Recommendations emphasised strengthened governance through shared leadership among trusts, establishment of regional pathology hubs akin to models in Manchester, enhancement of workforce pipelines in partnership with the Royal College of Physicians and the Royal College of Surgeons, and accelerated adoption of ISO accreditation standards. The Review proposed clearer responsibilities for the Care Quality Commission in oversight, greater interoperability of laboratory information systems drawing on precedents from NHS Scotland Digital, and incentives for research collaborations with academic centres such as the Francis Crick Institute and Wellcome Trust-funded units.

Reception and implementation

Responses varied among stakeholder organisations: professional bodies like the British Medical Association and the Royal College of Pathologists generally welcomed calls for modernization, while some integrated care systems and trusts expressed concern about implementation costs. NHS policy documents and planning guidance from NHS England referenced the Review when shaping initiatives on diagnostic services, and pilot programmes were launched in regions including Greater Manchester and London with involvement from university hospitals such as Guy's and St Thomas' NHS Foundation Trust and University College London Hospitals NHS Foundation Trust. Private sector diagnostics firms and laboratory networks engaged in procurement rounds influenced by the Review's emphasis on accreditation and interoperability.

Impact on clinical practice and policy

The Review accelerated discussions on workforce training across postgraduate pathways overseen by the Joint Royal Colleges of Physicians Training Board and contributed to investments in automation in laboratories serving trusts like Addenbrooke's Hospital and Royal Infirmary of Edinburgh. Policy shifts included incorporation of laboratory consolidation principles into NHS estate planning and capital programmes, alignment with National Institute for Health Research priorities for diagnostic innovation, and enhanced quality frameworks in line with the Care Quality Commission inspection regimes. Adoption of digital reporting workflows built on projects funded by organisations such as the Medical Research Council and partnerships with technology vendors.

Criticisms and controversies

Critics argued the Review underemphasised local laboratory autonomy and risks of service centralisation, citing concerns raised by regional commissioners and union bodies including the Royal College of Nursing. Some hospital trusts warned that consolidation proposals could jeopardise turnaround times for urgent tests used in oncological pathways overseen by bodies like NICE and the Cancer Research UK clinical networks. Debate also centred on procurement transparency and involvement of private providers, with scrutiny from parliamentary committees and coverage in outlets referencing inquiries into public-private partnerships exemplified by controversies around agencies such as Carillion and historical contracts with Serco.

Category:Health reviews Category:Pathology